GlassScriptPhysician profile
Kellyn R Perham
NPI 1841881778
$3,964.24
in general payments reported to CMS, 2019-2025
27 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $336 · 2022: $2,434 · 2023: $116 · 2024: $1,078.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $679 · Travel and Lodging: $515.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $679.10 |
| Travel and Lodging | $515.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $1,058.93 | 2021-2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Teva Pharmaceuticals USA, INC. | $614.98 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $262.21 | 2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $240.25 | 2022 | |
| Abbvie INC. | $221.24 | 2022 | |
| Janssen Pharmaceuticals, INC | $179.14 | 2021-2022 | |
| Livanova USA, INC. | $170.48 | 2021-2022 | |
| Neurocrine Biosciences, INC. | $165.43 | 2022 | |
| Lundbeck LLC | $158.22 | 2022 | |
| Baxter Healthcare | $99.71 | 2023 | Floseal, Perclot |
| Takeda Pharmaceuticals U.S.A., INC. | $77.65 | 2022 | |
| Sunovion Pharmaceuticals INC. | $74.68 | 2022 | |
| Avanir Pharmaceuticals, INC. | $72.50 | 2022 | |
| Noven Therapeutics, LLC | $67.90 | 2022 | |
| Alkermes, INC. | $62.23 | 2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Indivior INC. | $59.16 | 2022 | |
| Vanda Pharmaceuticals INC. | $55.45 | 2022 | |
| Innocoll Pharmaceuticals Limited | $55.21 | 2021 | |
| Medtronic, INC. | $51.48 | 2024 | Endurant Iis |
| Smith+Nephew, INC. | $42.96 | 2021-2023 | Pico 14 |
| Noven Pharmaceuticals, INC. | $38.12 | 2022 | |
| Bausch Health US, LLC | $34.60 | 2022 | |
| Almatica Pharma LLC | $27.66 | 2022 | |
| W. L. Gore & Associates, INC. | $24.77 | 2024 | Excluder Conformable Aaa Endoprosthesis With Active Control |
| Owp Pharmaceuticals, INC. | $21.00 | 2022 | |
| Biogen, INC. | $14.90 | 2022 | |
| Merck Sharp & Dohme LLC | $13.38 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kellyn Perham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.